91 Results

People

  1. Ladanyi
    Ladanyi
  2. Paik
    Paik
  3. Weiser
    Weiser
  4. Riely
    Riely
  5. Drilon
    Drilon
  6. Kris
    Kris
  7. Paty
    Paty
  8. Rekhtman
    Rekhtman
  9. Yu
    Yu
  10. Arcila
    Arcila

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (47)
  3. GSK Faculty (30)
  4. Human Oncology and Pathogenesis Program (27)
  5. Department of Pathology and Laboratory Medicine (26)
  6. Thoracic Oncology (26)
  7. Surgery (23)
  8. Tow Center for Developmental Oncology (TCDO) (19)
  9. Sloan Kettering Institute Postdocs (13)
  10. Genitourinary Oncology Service (12)
  1. "scatter factor receptor"
Formats
  1. Journal Article (79)
  2. Review (7)
  3. Correspondence (2)
  4. Editorial (2)
  5. Conference Paper (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (47)
  3. GSK Faculty (30)
  4. Human Oncology and Pathogenesis Program (27)
  5. Department of Pathology and Laboratory Medicine (26)
  6. Thoracic Oncology (26)

More Groups

People
  1. Marc Ladanyi (10)
  2. Paul Paik (10)
  3. Martin Weiser (7)
  4. Gregory Riely (6)
  5. Alexander Drilon (5)
  6. Helena Yu (5)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (8)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Proceedings of the National Academy of Sciences of the United States of America (5)
  3. Annals of Oncology (4)
  4. Cancer Discovery (3)
  5. Clinical Lung Cancer (3)
  6. Journal of Thoracic Oncology (3)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Elsevier Inc. (11)
  3. Elsevier Science, Inc. (8)
  4. Nature Publishing Group (7)
  5. Oxford University Press (7)
  6. National Academy of Sciences (5)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib versus sunitinib for untreated patients with advanced renal cell carcinoma of intermediate or poor risk: Subgroup analysis of the Alliance A031203 CABOSUN trial
    Journal Article

    George, D. J.; Hessel, C.; Halabi, S.; Michaelson, M. D.; Hahn, O.; Walsh, M.; Picus, J.; Small, E. J.; Dakhil, S.; Feldman, D. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Harnessing the genomic landscape of the small renal mass to guide clinical management
    Review

    Silagy, A. W.; Sanchez, A.; Manley, B. J.; Bensalah, K.; Bex, A.; Karam, J. A.; Ljungberg, B.; Shuch, B.; Hakimi, A. A.
    European Urology Focus (2019)

    Fulltext@MSK | Save
  • Familial kidney cancer: Implications of new syndromes and molecular insights
    Review

    Carlo, M. I.; Hakimi, A. A.; Stewart, G. D.; Bratslavsky, G.; Brugarolas, J.; Chen, Y. B.; Linehan, W. M.; Maher, E. R.; Merino, M. J.; Offit, K.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Genetics of human thyroid cancer cell lines-response
    Correspondence

    Landa, I.; Pozdeyev, N.; Knauf, J. A.; Haugen, B. R.; Fagin, J. A.; Schweppe, R. E.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • PD-L1 expression and clinical outcomes to cabozantinib, everolimus, and sunitinib in patients with metastatic renal cell carcinoma: Analysis of the randomized clinical trials METEOR and CABOSUN
    Journal Article

    Flaifel, A.; Xie, W.; Braun, D. A.; Ficial, M.; Bakouny, Z.; Nassar, A. H.; Jennings, R. B.; Escudier, B.; George, D. J.; Motzer, R. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • ERBBal remedies: Combination therapy for EGFR-mutant lung cancers
    Journal Article

    Fan, P. D.; Yu, H. A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to systemic therapy in esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Chatila, W. K.; Hechtman, J. F.; Ku, G. Y.; Riches, J. C.; Tuvy, Y.; Kundra, R.; Bouvier, N.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • A first-in-class TWIST1 inhibitor with activity in oncogene-driven lung cancer
    Journal Article

    Yochum, Z. A.; Cades, J.; Mazzacurati, L.; Neumann, N. M.; Khetarpal, S. K.; Chatterjee, S.; Wang, H.; Attar, M. A.; Huang, E. H. B.; Chatley, S. N.; more...
    Molecular Cancer Research (2017)

    Fulltext@MSK | Save
  • CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
    Journal Article

    Thayaparan, T.; Petrovic, R. M.; Achkova, D. Y.; Zabinski, T.; Davies, D. M.; Klampatsa, A.; Parente-Pereira, A. C.; Whilding, L. M.; van der Stegen, S. J. C.; Woodman, N.; more...
    OncoImmunology (2017)

    Fulltext@MSK | Save